• Profile
Close

Impact of pneumococcal vaccination on pneumonia hospitalizations and related costs in Ontario: A population-based ecological study

Clinical Infectious Diseases Evidence based | Feb 06, 2018

Luca DL, et al. - The population-level impact of pneumococcal conjugate vaccine (PCV) on pneumonia hospitalizations and related costs were assessed. Researchers observed substantial reductions in pneumonia hospitalizations and related healthcare costs in relation to the publicly funded PCV immunization program. This was evident among both young children eligible for publicly funded vaccination and other age groups not included in the publicly funded program.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay